-
1
-
-
0033059396
-
Mass spectrometric quantification of amino acid oxidation products in protein: Insights into pathways that promote LDL oxidation in the human artery wall
-
J.W. Heinecke Mass spectrometric quantification of amino acid oxidation products in protein Insights into pathways that promote LDL oxidation in the human artery wall FASEB J 13 1999 1113 1120
-
(1999)
FASEB J
, vol.13
, pp. 1113-1120
-
-
Heinecke, J.W.1
-
2
-
-
0030979720
-
3-chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima
-
S.L. Hazen, J.W. Heinecke 3-chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima J Clin Invest 99 1997 2075 2081
-
(1997)
J Clin Invest
, vol.99
, pp. 2075-2081
-
-
Hazen, S.L.1
Heinecke, J.W.2
-
3
-
-
0036833743
-
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
-
J. Himmelfarb, P. Stenvinkel, T.A. Ikizler The elephant in uremia Oxidant stress as a unifying concept of cardiovascular disease in uremia Kidney Int 62 2002 1524 1538
-
(2002)
Kidney Int
, vol.62
, pp. 1524-1538
-
-
Himmelfarb, J.1
Stenvinkel, P.2
Ikizler, T.A.3
-
4
-
-
0031749824
-
Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension
-
N.D. Vaziri, F. Oveisi, Y. Ding Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension Kidney Int 53 1998 1748 1754
-
(1998)
Kidney Int
, vol.53
, pp. 1748-1754
-
-
Vaziri, N.D.1
Oveisi, F.2
Ding, Y.3
-
5
-
-
0035046519
-
Elevated plasma F2-isoprostanes in patients on long-term hemodialysis
-
G.J. Handelman, M.F. Walter, R. Adhikarla Elevated plasma F2-isoprostanes in patients on long-term hemodialysis Kidney Int 51 2001 1960 1966
-
(2001)
Kidney Int
, vol.51
, pp. 1960-1966
-
-
Handelman, G.J.1
Walter, M.F.2
Adhikarla, R.3
-
6
-
-
0036707471
-
Plasma F2 isoprostane levels are elevated in chronic hemodialysis patients
-
T.A. Ikizler, J.D. Morrow, L.J. Roberts Plasma F2 isoprostane levels are elevated in chronic hemodialysis patients Clin Nephrol 58 2002 190 197
-
(2002)
Clin Nephrol
, vol.58
, pp. 190-197
-
-
Ikizler, T.A.1
Morrow, J.D.2
Roberts, L.J.3
-
7
-
-
0034738004
-
Isolevuglandin-protein adducts in humans: Products of free radical-induced lipid oxidation through the isoprostane pathway
-
R.G. Salomon, E. Batyreva, K. Kaur Isolevuglandin-protein adducts in humans Products of free radical-induced lipid oxidation through the isoprostane pathway Biochim Biophys Acta 1485 2000 225 235
-
(2000)
Biochim Biophys Acta
, vol.1485
, pp. 225-235
-
-
Salomon, R.G.1
Batyreva, E.2
Kaur, K.3
-
8
-
-
0033929845
-
HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques
-
R.G. Salomon, K. Kaur, E. Podrez HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques Chem Res Toxicol 13 2000 557 564
-
(2000)
Chem Res Toxicol
, vol.13
, pp. 557-564
-
-
Salomon, R.G.1
Kaur, K.2
Podrez, E.3
-
9
-
-
0037839029
-
Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure
-
I. Ceballos-Picot, V. Witko-Sarsat, M. Merad-Boudia Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure Free Radic Biol Med 21 1996 845 853
-
(1996)
Free Radic Biol Med
, vol.21
, pp. 845-853
-
-
Ceballos-Picot, I.1
Witko-Sarsat, V.2
Merad-Boudia, M.3
-
10
-
-
0028914996
-
Reduced, free, and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure
-
B. Hultberg, A. Andersson, M. Arnadottir Reduced, free, and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure Nephron 70 1995 62 67
-
(1995)
Nephron
, vol.70
, pp. 62-67
-
-
Hultberg, B.1
Andersson, A.2
Arnadottir, M.3
-
11
-
-
0036151655
-
Plasma aminothiol oxidation in chronic renal failure
-
J. Himmelfarb, E. McMenamin, E. McMonagle Plasma aminothiol oxidation in chronic renal failure Kidney Int 61 2002 705 716
-
(2002)
Kidney Int
, vol.61
, pp. 705-716
-
-
Himmelfarb, J.1
McMenamin, E.2
McMonagle, E.3
-
12
-
-
0033667376
-
Plasma protein thiol oxidation and carbonyl formation in chronic renal failure
-
J. Himmelfarb, E. McMonagle, E. McMenamin Plasma protein thiol oxidation and carbonyl formation in chronic renal failure Kidney Int 58 2000 2571 2578
-
(2000)
Kidney Int
, vol.58
, pp. 2571-2578
-
-
Himmelfarb, J.1
McMonagle, E.2
McMenamin, E.3
-
13
-
-
0035160460
-
Manifestations of oxidant stress in uremia
-
J. Himmelfarb, E. McMonagle Manifestations of oxidant stress in uremia Blood Purif 19 2001 200 205
-
(2001)
Blood Purif
, vol.19
, pp. 200-205
-
-
Himmelfarb, J.1
McMonagle, E.2
-
14
-
-
0034120352
-
Mechanisms for the formation of glycoxidation products in end-stage renal disease
-
M.R. Weiss, P. Erhard, F.A. Kader-Attia Mechanisms for the formation of glycoxidation products in end-stage renal disease Kidney Int 57 2001 2571 2585
-
(2001)
Kidney Int
, vol.57
, pp. 2571-2585
-
-
Weiss, M.R.1
Erhard, P.2
Kader-Attia, F.A.3
-
15
-
-
0031785582
-
Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: Carbonyl stress in uremia
-
T. Miyata, Y. Ueda, Y. Izuhara Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product Carbonyl stress in uremia J Am Soc Nephrol 9 1998 2349 2356
-
(1998)
J Am Soc Nephrol
, vol.9
, pp. 2349-2356
-
-
Miyata, T.1
Ueda, Y.2
Izuhara, Y.3
-
16
-
-
0037213489
-
Oxidative stress and dysregulation of superoxide dismutase, NADPH oxidase and xanthine oxidase in renal insufficiency
-
N.D. Vaziri, M. Dicus, N.D. Ho Oxidative stress and dysregulation of superoxide dismutase, NADPH oxidase and xanthine oxidase in renal insufficiency Kidney Int 63 2003 179 185
-
(2003)
Kidney Int
, vol.63
, pp. 179-185
-
-
Vaziri, N.D.1
Dicus, M.2
Ho, N.D.3
-
17
-
-
0028806180
-
Effect of chronic experimental renal insufficiency on urate metabolism
-
N.D. Vaziri, R.W. Freel, M. Hatch Effect of chronic experimental renal insufficiency on urate metabolism J Am Soc Nephrol 6 1995 1313 1317
-
(1995)
J Am Soc Nephrol
, vol.6
, pp. 1313-1317
-
-
Vaziri, N.D.1
Freel, R.W.2
Hatch, M.3
-
18
-
-
0034677947
-
NAD(P)H oxidase: Role in cardiovascular biology and disease
-
K.K. Griendling, D. Sorescu, M. Ushio-Fukai NAD(P)H oxidase Role in cardiovascular biology and disease Circ Res 86 2000 494 501
-
(2000)
Circ Res
, vol.86
, pp. 494-501
-
-
Griendling, K.K.1
Sorescu, D.2
Ushio-Fukai, M.3
-
19
-
-
0036155515
-
Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in chronic renal insufficiency
-
N.D. Vaziri, Z. Ni, F. Oveisi Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in chronic renal insufficiency Hypertension 39 2002 135 141
-
(2002)
Hypertension
, vol.39
, pp. 135-141
-
-
Vaziri, N.D.1
Ni, Z.2
Oveisi, F.3
-
20
-
-
0036154076
-
Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide
-
G. Hasdan, S. Benchetrit, G. Rashid Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide Kidney Int 61 2002 586 590
-
(2002)
Kidney Int
, vol.61
, pp. 586-590
-
-
Hasdan, G.1
Benchetrit, S.2
Rashid, G.3
-
21
-
-
0034874120
-
Increased tyrosine nitration of the brain in chronic renal insufficiency: Reversal by antioxidant therapy
-
G. Deng, N.D. Vaziri, B. Jabbari Increased tyrosine nitration of the brain in chronic renal insufficiency Reversal by antioxidant therapy J Am Soc Nephrol 12 2001 1892 1898
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 1892-1898
-
-
Deng, G.1
Vaziri, N.D.2
Jabbari, B.3
-
22
-
-
0025292686
-
Reduced superoxide dismutase activity in erythrocytes of dialysis patients: A possible factor in the etiology of uremic anemia
-
R. Shainkin-Kestenbaum, C. Caruso, G.M. Berlyne Reduced superoxide dismutase activity in erythrocytes of dialysis patients A possible factor in the etiology of uremic anemia Nephron 55 1990 251 253
-
(1990)
Nephron
, vol.55
, pp. 251-253
-
-
Shainkin-Kestenbaum, R.1
Caruso, C.2
Berlyne, G.M.3
-
23
-
-
0028366516
-
Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure
-
I. Durak, O. Akyol, E. Basesme Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure Nephron 66 1994 76 80
-
(1994)
Nephron
, vol.66
, pp. 76-80
-
-
Durak, I.1
Akyol, O.2
Basesme, E.3
-
24
-
-
0022258403
-
Anemia of end-stage renal disease (ESRD)
-
J.W. Eschbach, J.W. Adamson Anemia of end-stage renal disease (ESRD) Kidney Int 28 1985 1 5
-
(1985)
Kidney Int
, vol.28
, pp. 1-5
-
-
Eschbach, J.W.1
Adamson, J.W.2
-
25
-
-
0026089757
-
Erythrocyte defense mechanisms against free oxygen radicals in haemodialysed uraemic children
-
S. Turi, I. Nemeth, I. Vargha Erythrocyte defense mechanisms against free oxygen radicals in haemodialysed uraemic children Pediatr Nephrol 5 1991 179 183
-
(1991)
Pediatr Nephrol
, vol.5
, pp. 179-183
-
-
Turi, S.1
Nemeth, I.2
Vargha, I.3
-
26
-
-
0031968667
-
Downregulation of nitric oxide synthase in chronic renal insufficiency: Role of excess PTH
-
N.D. Vaziri, Z. Ni, X.Q. Wang Downregulation of nitric oxide synthase in chronic renal insufficiency Role of excess PTH Am J Physiol 274 1998 642 649
-
(1998)
Am J Physiol
, vol.274
, pp. 642-649
-
-
Vaziri, N.D.1
Ni, Z.2
Wang, X.Q.3
-
27
-
-
0021361593
-
Effects of alpha-tocopherol administration on red blood cell membrane lipid peroxidation in hemodialysis patients
-
O. Giardini, M. Taccone-Gallucci, R. Lubrano Effects of alpha-tocopherol administration on red blood cell membrane lipid peroxidation in hemodialysis patients Clin Nephrol 21 1984 174 177
-
(1984)
Clin Nephrol
, vol.21
, pp. 174-177
-
-
Giardini, O.1
Taccone-Gallucci, M.2
Lubrano, R.3
-
28
-
-
0021849112
-
Effects of large dose vitamin e supplementation on anemia in hemodialysis patients
-
K. Ono Effects of large dose vitamin E supplementation on anemia in hemodialysis patients Nephron 40 1985 440 445
-
(1985)
Nephron
, vol.40
, pp. 440-445
-
-
Ono, K.1
-
29
-
-
0022468072
-
Relationship between red blood cell lipid peroxidation, plasma hemoglobin, and red blood cell osmotic resistance before and after vitamin e supplementation in hemodialysis patients
-
R. Lubrano, M. Taccone-Gallucci, V. Mazzarella Relationship between red blood cell lipid peroxidation, plasma hemoglobin, and red blood cell osmotic resistance before and after vitamin E supplementation in hemodialysis patients Artif Organs 10 1986 245 250
-
(1986)
Artif Organs
, vol.10
, pp. 245-250
-
-
Lubrano, R.1
Taccone-Gallucci, M.2
Mazzarella, V.3
-
30
-
-
0030666412
-
Erythropoietin and oxidative stress in haemodialysis: Beneficial effects of vitamin e supplementation
-
J.P. Cristol, J.Y. Bosc, S. Badiou Erythropoietin and oxidative stress in haemodialysis Beneficial effects of vitamin E supplementation Nephrol Dial Transplant 12 1997 2312 2317
-
(1997)
Nephrol Dial Transplant
, vol.12
, pp. 2312-2317
-
-
Cristol, J.P.1
Bosc, J.Y.2
Badiou, S.3
-
31
-
-
0033864568
-
Assessment of inflammation and nutrition in patients with end-stage renal disease
-
B.R. Don, G.A. Kaysen Assessment of inflammation and nutrition in patients with end-stage renal disease J Nephrol 13 2000 249 259
-
(2000)
J Nephrol
, vol.13
, pp. 249-259
-
-
Don, B.R.1
Kaysen, G.A.2
-
32
-
-
0036719916
-
Inflammation in end-stage renal disease: Sources, consequences, and therapy
-
P. Stenvinkel, A. Alvestrand Inflammation in end-stage renal disease Sources, consequences, and therapy Semin Dial 15 2002 329 337
-
(2002)
Semin Dial
, vol.15
, pp. 329-337
-
-
Stenvinkel, P.1
Alvestrand, A.2
-
33
-
-
0029910233
-
Vitamin C: Antioxidant or pro-oxidant in vivo?
-
B. Halliwell Vitamin C Antioxidant or pro-oxidant in vivo? Free Radic Res 25 1996 439 454
-
(1996)
Free Radic Res
, vol.25
, pp. 439-454
-
-
Halliwell, B.1
-
34
-
-
0034619027
-
Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE): Randomized placebo-controlled trial
-
M. Boaz, S. Smetana, T. Weinstein Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE) Randomized placebo-controlled trial Lancet 356 2000 1213 1218
-
(2000)
Lancet
, vol.356
, pp. 1213-1218
-
-
Boaz, M.1
Smetana, S.2
Weinstein, T.3
|